High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study

Author(s):: Drechsler, C.; Evenepoel, P.; Vervloet, M.G.; Wanner, C.; Ketteler, M.; Marx, N.; Floege, J.; Dekker, F.W. (0000-0002-2433-2494); Brandenburg, V.M.; NECOSAD Study Grp

Published: 2015
Publication type: Article / Letter to editor

CKD-MBDend-stage renal diseasemortalityrenal osteodystrophysclerostin

Date issued: 2015-02-28
Language: English
Is part of: Nephrology Dialysis Transplantation (2015), Vol. 30, no. 2, p. 288-293
hdl: 1887/101717
doi: 10.1093/ndt/gfu301